These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 23193161)

  • 21. CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
    Ntaios G; Lip GY; Makaritsis K; Papavasileiou V; Vemmou A; Koroboki E; Savvari P; Manios E; Milionis H; Vemmos K
    Neurology; 2013 Mar; 80(11):1009-17. PubMed ID: 23408865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CHA2DS2-VASc and SAMe-TT2R2 scores as predictors of recurrence for nonvalvular atrial fibrillation patients on vitamin K antagonists after radiofrequency catheter ablation.
    Zhao J; Zhou D; Chen M; Zhuo C; Lin Z; Zheng L; Wang Q
    J Cardiovasc Med (Hagerstown); 2020 Mar; 21(3):200-208. PubMed ID: 31977539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of catheter ablation on clinical outcomes in patients with atrial fibrillation and significant functional mitral regurgitation.
    Wu JT; Zhao DQ; Zhang FT; Liu XJ; Hu J; Zhang LM; Fan XW; Yang HT; Yan LJ; Liu JJ; Wang SL
    BMC Cardiovasc Disord; 2021 Dec; 21(1):587. PubMed ID: 34876011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catheter ablation of atrial fibrillation in patients with heart failure: impact of maintaining sinus rhythm on heart failure status and long-term rates of stroke and death.
    Ullah W; Ling LH; Prabhu S; Lee G; Kistler P; Finlay MC; Earley MJ; Sporton S; Bashir Y; Betts TR; Rajappan K; Thomas G; Duncan E; Staniforth A; Mann I; Chow A; Lambiase P; Schilling RJ; Hunter RJ
    Europace; 2016 May; 18(5):679-86. PubMed ID: 26843584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter: Insights from the ATHENA study.
    Vamos M; Calkins H; Kowey PR; Torp-Pedersen CT; Corp Dit Genti V; Wieloch M; Koren A; Hohnloser SH
    Clin Cardiol; 2020 Mar; 43(3):291-297. PubMed ID: 31872901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of stroke and mortality in patients with atrial fibrillation by catheter ablation? Finally, tackling the hard endpoints.
    Kornej J; Lip GY; Bollmann A
    Europace; 2013 May; 15(5):620-2. PubMed ID: 23233210
    [No Abstract]   [Full Text] [Related]  

  • 28. Prognostic value of high-sensitive troponin T for predicting cardiovascular events after atrial fibrillation ablation.
    Tamura S; Doi A; Matsuo M; Katayama H; Yoshiyama T; Tatsumi H; Izumiya Y; Yoshiyama M
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1475-1482. PubMed ID: 31192482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five-year impact of catheter ablation for atrial fibrillation in patients with a prior history of stroke.
    Bunch TJ; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Jacobs V; Mallender C; Osborn JS; Weiss JP
    J Cardiovasc Electrophysiol; 2018 Feb; 29(2):221-226. PubMed ID: 29131434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five-year follow-up outcome after catheter ablation of persistent atrial fibrillation using a sequential biatrial linear defragmentation approach: What does atrial fibrillation termination during the procedure imply?
    Miyazaki S; Taniguchi H; Kusa S; Nakamura H; Hachiya H; Hirao K; Iesaka Y
    Heart Rhythm; 2017 Jan; 14(1):34-40. PubMed ID: 27590435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report.
    Fumagalli S; Said SA; Laroche C; Gabbai D; Boni S; Marchionni N; Boriani G; Maggioni AP; Musialik-Lydka A; Sokal A; Petersen J; Crijns HJGM; Lip GYH;
    Eur Heart J Cardiovasc Pharmacother; 2018 Jul; 4(3):172-179. PubMed ID: 29309557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden.
    Rillig A; Borof K; Breithardt G; Camm AJ; Crijns HJGM; Goette A; Kuck KH; Metzner A; Vardas P; Vettorazzi E; Wegscheider K; Zapf A; Kirchhof P
    Circulation; 2022 Sep; 146(11):836-847. PubMed ID: 35968706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of repeat catheter ablation vs. antiarrhythmic drug therapy among patients with recurrent atrial tachycardia/atrial fibrillation after atrial fibrillation catheter ablation: data from CHINA-AF registry.
    Zhou L; He L; Wang W; Li C; Li S; Tang R; Sang C; Liu N; Jiang C; Yu R; Long D; Du X; Dong J; Ma C
    Europace; 2023 Feb; 25(2):382-389. PubMed ID: 36156137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis of medical management versus catheter ablation for atrial fibrillation.
    Mao YJ; Wang H; Chen JX; Huang PF
    Rev Cardiovasc Med; 2020 Sep; 21(3):419-432. PubMed ID: 33070546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health outcomes with catheter ablation or antiarrhythmic drug therapy in atrial fibrillation: results of a propensity-matched analysis.
    Reynolds MR; Gunnarsson CL; Hunter TD; Ladapo JA; March JL; Zhang M; Hao SC
    Circ Cardiovasc Qual Outcomes; 2012 Mar; 5(2):171-81. PubMed ID: 22373904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA
    Rivera-Caravaca JM; Roldán V; Esteve-Pastor MA; Valdés M; Vicente V; Lip GYH; Marín F
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28729407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CHA
    Harb SC; Wang TKM; Nemer D; Wu Y; Cho L; Menon V; Wazni O; Cremer PC; Jaber W
    Open Heart; 2021 Nov; 8(2):. PubMed ID: 34815301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CHA2DS2-VASc score and fibrinogen concentration in patients with atrial fibrillation.
    Semczuk-Kaczmarek K; Płatek AE; Ryś A; Adamowicz J; Legosz P; Kotkowski M; Dudzik-Płocica A; Gorko D; Szymański FM; Filipiak KJ
    Adv Clin Exp Med; 2019 Nov; 28(11):1451-1457. PubMed ID: 31596555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catheter ablation improves outcomes and quality of life in Japanese patients with early-stage atrial fibrillation: A retrospective cohort study.
    Seki Y; Fujisawa T; Ikemura N; Ibe S; Tsuzuki I; Hashimoto K; Yamashita T; Miyama H; Niimi N; Suzuki M; Negishi K; Katsumata Y; Kimura T; Fukuda K; Kohsaka S; Takatsuki S
    Heart Rhythm; 2022 Jul; 19(7):1076-1083. PubMed ID: 35183738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CHA2DS2-VAS(C) and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation.
    Glotzer TV; Hellkamp AS; Lee KL; Lamas GA
    Can J Cardiol; 2015 Aug; 31(8):1004-11. PubMed ID: 26076964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.